JP Morgan Maintains Neutral on Gentex, Raises Price Target to $37
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Ryan Brinkman has maintained a Neutral rating on Gentex (NASDAQ:GNTX) and increased the price target from $36 to $37.
January 25, 2024 | 11:49 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan analyst Ryan Brinkman reaffirmed a Neutral rating on Gentex and raised the price target to $37, indicating a potential upside from the previous target.
The increase in price target by JP Morgan suggests a positive outlook on Gentex's valuation, which could lead to a short-term increase in the stock price. However, the Neutral rating implies that the analyst does not see significant momentum beyond the revised target, tempering the potential impact.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100